JaxBio (Health Care) — Funding, Investors & Signals 2026

JaxBio

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Founded 2022 11 employees Grant Total: $2.50M Health Care

JaxBio is a pioneering company in the healthcare industry, dedicated to transforming cancer diagnosis and management with their innovative blood test technology. The company's slogan "At JaxBio we develop a blood test for fast, cheap, and highly sensitive diagnosis of cancer" encapsulates their mission to simplify, expedite, and enhance the precision of cancer detection. Their groundbreaking blood test offers a significant advancement over traditional methods and liquid biopsies, delivering faster and more accurate results at a lower cost. Utilizing state-of-the-art artificial intelligence (AI) algorithms, JaxBio identifies effective biomarker sets that efficiently detect various types and subtypes of cancer at different stages. The company's impact extends beyond initial diagnosis, as their tests play a crucial role in monitoring disease status and forecasting patient response to therapy. Notably, JaxBio's platform technology has potential applications in a spectrum of diseases, including various cancer types, neurodegenerative diseases, and heart conditions. The latest investment of $2.50 million from the EIC Accelerator in July 2024 signifies a significant endorsement of JaxBio's groundbreaking approach to cancer diagnosis. As JaxBio continues to innovate and evolve, their disruptive blood test technology promises to empower healthcare providers and patients with timely and informed decision-making in critical moments. For more insights, consider engaging with JaxBio directly.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	••••••	1	•••• ••••	16 Jul 2024

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

••••••

•••• ••••

16 Jul 2024

FAQ About JaxBio

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

JaxBio was founded in 2022.

JaxBio operates in the following industries: Health Care.

JaxBio has approximately 11 employees.

JaxBio has completed 1 funding round, raising a total of $2.50M. The latest funding stage is Grant.

Top alternatives and competitors to JaxBio include Volition, Mirxes, Savicell, Micromedic Technologies Ltd., Beacon Biomedical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

JaxBio and Volition are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

JaxBio

General Information

Track JaxBio

Discover More

About JaxBio

Funding Rounds & Investors (1)

JaxBio Alternatives & Competitors

FAQ About JaxBio

Don't just browse. Track.